Since we opened in 1998, thousands of babies have been born through fertility treatment at Michigan Reproductive Medicine. By keeping up with current technology and science, the dedicated research efforts of Dr. Mersol-Barg and our exceptional staff enables us to provide our patients with the best possible care and the greatest chance for conception.
There has been a dramatic improvement in egg and embryo freezing technology by way of vitrification process. Outcomes with frozen embryo transfers is as good or better than outcomes with fresh embryo transfers. The majority of our patients now have frozen embryo transfers. This substantially reduces the risk of ovarian hyperstimulation syndrome (OHSS) compared to fresh embryo transfers. More patients are also selecting preimplantation genetic testing (PGT) which requires 3 weeks after egg harvest to have PGT results return. Therefore embryo banking (freezing) is necessary.
With a 67% pregnancy rate in women under 35, Michigan Reproductive Medicine’s in vitro fertilization (IVF) success rates are among the best in the US. While our success rates have been consistently above the national average, we understand that the treatment of infertility is more than just a published IVF success rate–particularly a rate that may be several years old.
Many patients have shared their frustration with the 2 year or more lag in IVF success rates reported by the CDC (2020) and SART (2019). We believe that the current quality of our care is best measured by how we have treated our most recent patients. This is why we are presenting our IVF success rates for 2022. We present pregnancy rates per embryo transfer. Live birth rates will require about a year further allowing for 9 months of pregnancy. We report our live birth rates through the CDC.
For information on Elective Single Embryo Transfer (eSET) and success rates, click here.
Please note: a comparison of clinic success rates may not be meaningful because a patient’s medical history, treatment approaches and entrance criteria for assisted reproductive technology (ART) may vary from clinic to clinic. For example, some clinics may direct patients to IVF therapy very quickly when more traditional, less costly treatments such as ovulation induction, IUI or surgery may offer a good opportunity for success. Inclusion of pregnancy rates for these patients may lead to inflated IVF success rates for clinics that rush patients to IVF.
Note: Age 41-42 category: only 1 cycle with fresh embryo transfer. Pregnancy did not result. All other cycles in 41-42 age category planned embryo banking and subsequent frozen embryo transfer.
